← Back to Patent Explorer
US4861580A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition using salt form of organic acid derivative of alpha-tocopheral

Assignee: Elan Pharmaceuticals LLC
•
Filing: 1986-09-24
•
Granted: 1989-08-29
•
Expires: 2006-09-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.

Inventors

  • 👤 Andrew S. Janoff
  • 👤 Lois E. Bolcsak
  • 👤 Alan L. Weiner
  • 👤 Paul A. Tremblay
  • 👤 Michael V. W. Bergamini
  • 👤 Robert L. Suddith

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 00:47
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1277; A61K31/00; A61K31/33; A61K31/335; A61K31/35; A61K31/352; A61K31/353; A61K31/355; A61K9/1271; A61K9/1272; A61P; A61P25/00; A61P25/04; A61P27/00; A61P27/02; A61P29/00; A61P31/00; A61P31/04; A61P31/10; A61P31/12; A61P33/00; A61P33/10; A61P37/00; A61P37/02; A61P37/06; Y; Y10; Y10S; Y10S436/00; Y10S436/829; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984

Claims Analysis

Total Claims: 53
Claim 1
Independent Claim 23 words
A composition comprising a tris(hydroxymethyl)aminomethane, a 2-amino-2-methyl-1,3-propanediol, a 2-aminoethanol, a bis-tris-propane, or a triethanolamine salt form of an organic acid derivative of alpha-tocopherol.
Claim 2
Dependent Claim 23 words
A composition comprising a tris(hydroxymethyl)aminomethane, a 2-amino-2-methyl-1,3-propanediol, a 2-aminoethanol, a bis-tris-propane, or a triethanolamine salt form of an organic acid derivative of alpha-tocopherol.
Claim 3
Dependent Claim 12 words
The composition according to claim 1 in which the alpha-tocopherol is D-alpha-tocopherol.
Claim 4
Dependent Claim 17 words
A pharmaceutical composition comprising the composition according to claim 2 and a pharmaceutically acceptable carrier or diluent.
Claim 5
Dependent Claim 19 words
The composition according to claim 1 comprising a tris(hydroxymethyl)aminomethane salt form of an organic acid derivative of a alpha-tocopherol.
Claim 6
Dependent Claim 23 words
The composition according to claim 1 in which the organic acid derivative comprises a carboxylic acid, a dicarboxylic acid or a polycarboxylic acid.
Claim 7
Dependent Claim 22 words
The composition according to claim 5 in which the carboxylic acid is an aliphatic carboxylic acid containing up to five carbon atoms.
Claim 8
Dependent Claim 16 words
The composition according to claim 5 in which the dicarboxylic acid comprises an aliphatic dicarboxylic acid.
Claim 9
Dependent Claim 18 words
The composition according to claim 7 in which the aliphatic dicarboxylic acid contains up to seven carbon atoms.
Claim 10
Dependent Claim 15 words
The composition according to claim 8 in which the aliphatic dicarboxylic acid is succinic acid.
Claim 11
Dependent Claim 22 words
The composition according to claim 1 in which the organic acid is an hydroxy acid, an amino acid or a polyamino acid.
Claim 12
Dependent Claim 17 words
The composition according to claim 1 comprising the tris(hydroxymethyl)aminomethane salt form of a hemisuccinate derivative of alpha-tocopherol.
Claim 13
Dependent Claim 15 words
The composition, according to claim 1 in which the composition additionally comprises a bioactive agent.
Claim 14
Dependent Claim 24 words
The composition according to claim 12 in which the bioactive agent is selected from the group consisting of antibacterial, antifungal, antiviral and antiparasitic compounds.
Claim 15
Dependent Claim 32 words
The composition according to claim 13 in which the antifungal compound is miconazole, terconazole, econazole, isoconazole, tioconazole, bifonazole, clotrimazole, ketoconazole, butaconazole, itraconazole, oxiconazole, fenticonazole, nystatin, naftifine, amphotericin B, zinoconazole or ciclopirox olamine.
Claim 16
Dependent Claim 23 words
The composition according to claim 12 in which the bioactive agent is selected from the group consisting of peptides, proteins, glycoproteins and lipoproteins.
Claim 17
Dependent Claim 14 words
The composition according to claim 15 in which the bioactive agent comprises growth hormone.
Claim 18
Dependent Claim 25 words
The composition according to claim 12 in which the bioactive agent is selected from the group consisting of dyes, radiolabels, radio-opaque compounds and fluorescent compounds.
Claim 19
Dependent Claim 25 words
The composition according to claim 12 in which the bioactive agent is selected from the group consisting of anti-inflammatory, antiglaucoma, mydriatic, analgesic and anesthetic compounds.
Claim 20
Dependent Claim 13 words
The composition according to claim 12 in which the bioactive agent comprises pilocarpine.
Claim 21
Dependent Claim 19 words
The composition according to claim 12 in which the bioactive agent comprises a narcotic, a psychoactive or anxiolytic agent.
Claim 22
Dependent Claim 14 words
The composition according to claim 12 in which the bioactive agent comprises a vitamin.
Claim 23
Dependent Claim 14 words
The composition according to claim 12 in which the organic acid is succinic acid.
Claim 24
Dependent Claim 24 words
A composition comprising a salt form of an organic acid derivative of alpha-tocopherol wherein the salt form is derived from an ionizable bioactive agent.
Claim 25
Dependent Claim 24 words
A composition comprising a salt form of an organic acid derivative of alpha-tocopherol wherein the salt form is derived from an ionizable bioactive agent.
Claim 26
Dependent Claim 14 words
The composition according to claim 23 in which the organic acid is succinic acid.
Claim 27
Dependent Claim 15 words
The composition according to claim 23 in which ionizable bioactive agent comprises an antifungal compound.
Claim 28
Dependent Claim 32 words
The composition according to claim 23 in which the antifungal compound is miconazole, terconazole, econazole, isoconazole, tioconazole, bifonazole, clotrimazole, ketoconazole, butaconazole, itraconazole, oxiconazole, fenticonazole, nystatin, naftifine, amphotericin B, zinoconazole or ciclopirox olamine.
Claim 29
Dependent Claim 28 words
The composition according to claim 23 in which the ionizable bioactive agent is a peptide, protein, glycoprotein or lipoprotein salt form of an organic acid derivative of alpha-tocopherol.
Claim 30
Dependent Claim 24 words
The composition according to claim 23 in which the ionizable bioactive agent is a pilocarpine salt form of an organic acid derivative of alpha-tocopherol.
Claim 31
Dependent Claim 14 words
The composition according to claim 28 additionally comprising a mucomimetic agent and a preservative.
Claim 32
Dependent Claim 26 words
The composition according to claim 29 wherein the mucomimetic agent is selected from the group consisting of hyaluronic acid, chondroitin sulfate, hydroxylpropyl methylcellulose, and polyvinyl alcohol.
Claim 33
Dependent Claim 16 words
The composition according to claim 30 wherein the mucomimetic agent is hydroxypropyl methylcellulose or polyvinyl alcohol.
Claim 34
Dependent Claim 21 words
A method of treating glaucoma comprising administering an anti-glaucoma-effective amount of the pharmaceutical composition according to claim 30 to a subject.
Claim 35
Dependent Claim 16 words
The composition according to claim 29 wherein the preservative is sorbic acid EDTA or benzylkonium chloride.
Claim 36
Dependent Claim 25 words
A composition comprising a salt form of an organic acid derivative of a sterol and a salt form of an organic acid derivative of alpha-tocopherol.
Claim 37
Dependent Claim 25 words
A composition comprising a salt form of an organic acid derivative of a sterol and a salt form of an organic acid derivative of alpha-tocopherol.
Claim 38
Dependent Claim 11 words
The composition according to claim 34 additionally comprising a bioactive agent.
Claim 39
Dependent Claim 23 words
The composition according to claim 35 wherein the bioactive agent is selected from the group consisting of peptides, polypeptides, proteins, glycoproteins, and lipoproteins.
Claim 40
Dependent Claim 13 words
The composition according to claim 36 wherein the polypeptide is an immunosuppressive agent.
Claim 41
Dependent Claim 12 words
The composition according to claim 36 wherein the polypeptide is cyclosporin A.
Claim 42
Dependent Claim 18 words
A composition according to claim 34 in which at least one salt form comprises an ionizable bioactive agent.
Claim 43
Dependent Claim 23 words
The composition according to claim 34 wherein the bioactive agent is selected from the group consisting of antibacterial, antifungal, antiviral and antiparasitic compounds.
Claim 44
Dependent Claim 24 words
The composition according to claim 34 wherein the bioactive agents is selected from the group consisting of dyes, radiolabels, radio-opque compounds and fluorescent compounds.
Claim 45
Dependent Claim 24 words
The composition according to claim 34 wherein the bioactive agent is selected from the group consisting of anti-inflammatory, antiglaucoma, mydriatic, analgesic, and anesthetic compounds.
Claim 46
Dependent Claim 17 words
A pharmaceutical composition comprising the composition according to claim 34 and a pharmaceutically acceptable carrier or diluent.
Claim 47
Dependent Claim 20 words
The composition according to claim 34 wherein the sterol is cholesterol hemisuccinate tris(hydroxymethyl)aminomethane and the alpha-tocopherol is alpha-tocopherol hemisuccinate tris(hydroxymethyl)aminomethane.
Claim 48
Dependent Claim 11 words
The composition according to claim 44 additionally comprising a bioactive agent.
Claim 49
Dependent Claim 16 words
A pharmaceutical composition comprising the composition of claim 44 and a pharmaceutically acceptable carrier or diluent.
Claim 50
Dependent Claim 22 words
The composition according to claim 34 wherein the salt form of the sterol or the alpha-tocopherol is a bioactive agent salt form.
Claim 51
Dependent Claim 11 words
A composition/comprising cholesterol hemisuccinate tris(hydroxymethyl)aminomethane, alpha-tocopherol hemisuccinate tris(hydroxymethyl)aminomethane, and cyclosporin A.
Claim 52
Dependent Claim 11 words
A composition/comprising cholesterol hemisuccinate tris(hydroxymethyl)aminomethane, alpha-tocopherol hemisuccinate tris(hydroxymethyl)aminomethane, and cyclosporin A.
Claim 53
Dependent Claim 17 words
A pharmaceutical composition comprising the composition according to claim 48 and a pharmaceutically acceptable carrier or diluent.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-08-28 1993-02-27 1993-08-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-08-28 1997-02-27 1997-08-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-08-28 2001-02-27 2001-08-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag